<DOC>
	<DOCNO>NCT00864786</DOCNO>
	<brief_summary>Multiple dose safety pharmacokinetics healthy male subject</brief_summary>
	<brief_title>Multiple Dose Healthy Volunteer Safety Pharmacokinetics Study</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Healthy male subject age 18 55 year , inclusive ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test ) . Body Mass Index ( BMI ) approximately 18 30 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . A BMI low limit 17.5 kg/m2 may round 18.0 kg/m2 ; BMI upper limit 30.5 kg/m2 may round 30.0 kg/m2 acceptable inclusion . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) disease clinical finding screen . Any condition possibly affect drug absorption ( eg , gastrectomy ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Multiple dose safety pharmacokinetics study</keyword>
</DOC>